Attached files

file filename
EX-10.68 - SECURITIES PURCHASE AGREEMENT (SERIES E), DATED JUNE 30, 2020 - GUIDED THERAPEUTICS INCgthp_ex10-68.htm
EX-31 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - GUIDED THERAPEUTICS INCgthp_ex31.htm
EX-23.1 - CONSENTS OF EXPERTS AND COUNSEL - GUIDED THERAPEUTICS INCgthp_ex231.htm
EX-10.69 - SECURITIES PURCHASE AGREEMENT (SERIES F), DATED MARCH 31, 2020 - GUIDED THERAPEUTICS INCgthp_ex10-69.htm
EX-10.67 - EXCHANGE AGREEMENT WITH RICHARD FOWLER, DATED AS OF MARCH 22, 2021 - GUIDED THERAPEUTICS INCgthp_ex10-67.htm
EX-10.66 - CONSULTING AGREEMENT WITH RICHARD BLUMBERG, DATED AS OF MARCH 11, 2021 - GUIDED THERAPEUTICS INCgthp_ex10-66.htm
EX-10.65 - SECURITIES PURCHASE AGREEMENT WITH POWERUP, DATED AS OF FEBRUARY 10, 2021 - GUIDED THERAPEUTICS INCgthp_ex10-65.htm
EX-10.64 - SECURITIES PURCHASE AGREEMENT WITH POWERUP, DATED AS OF DECEMBER 24, 2020 - GUIDED THERAPEUTICS INCgthp_ex10-64.htm
EX-10.63 - EXCHANGE AGREEMENT WITH WILLIAM WELLS, DATED AS OF JULY 9, 2020 - GUIDED THERAPEUTICS INCgthp_ex10-63.htm
EX-10.62 - FINDERS FEE AGREEMENT WITH FCMI, DATED AS OF JUNE 11, 2020 - GUIDED THERAPEUTICS INCgthp_ex10-62.htm
EX-10.61 - SECURITIES PURCHASE AGREEMENT WITH AUCTUS, DATED AS OF MAY 27, 2020 - GUIDED THERAPEUTICS INCgthp_ex10-61.htm
EX-10.60 - DEBT FOR EQUITY EXCHANGE AGREEMENT WITH AUCTUS, DATED AS OF MAY 22, 2020 - GUIDED THERAPEUTICS INCgthp_ex1060.htm
EX-10.59 - FINDERS FEE AGREEMENT WITH JH DARBIE, DATED AS OF MAY 19, 2020 - GUIDED THERAPEUTICS INCgthp_ex1059.htm
EX-4.45 - FORM OF WARRANT - GUIDED THERAPEUTICS INCgthp_ex445.htm
EX-4.44 - NOTE PAYABLE AGREEMENT - GUIDED THERAPEUTICS INCgthp_ex444.htm
EX-4.43 - NOTE PAYABLE AGREEMENT - GUIDED THERAPEUTICS INCgthp_ex443.htm
EX-4.42 - FORM OF WARRANT - GUIDED THERAPEUTICS INCgthp_ex442.htm
EX-4.41 - FORM OF WARRANT - GUIDED THERAPEUTICS INCgthp_ex441.htm
EX-4.40 - FORM OF WARRANT - GUIDED THERAPEUTICS INCgthp_ex440.htm
EX-4.39 - FORM OF WARRANT - GUIDED THERAPEUTICS INCgthp_ex439.htm
EX-4.38 - FORM OF WARRANT - GUIDED THERAPEUTICS INCgthp_ex438.htm
EX-4.37 - FORM OF WARRANT - GUIDED THERAPEUTICS INCgthp_ex437.htm
EX-4.36 - FORM OF WARRANT - GUIDED THERAPEUTICS INCgthp_ex436.htm
EX-4.35 - FORM OF WARRANT - GUIDED THERAPEUTICS INCgthp_ex435.htm
EX-4.24 - CONVERTIBLE PROMISSORY NOTE - GUIDED THERAPEUTICS INCgthp_ex424.htm
EX-3.6 - CERTIFICATE OF DESIGNATION OF PREFERENCES - GUIDED THERAPEUTICS INCgthp_ex36.htm
EX-3.5 - ARTICLES OF INCORPORATION / BYLAWS - GUIDED THERAPEUTICS INCgthp_ex35.htm
10-K - ANNUAL REPORT - GUIDED THERAPEUTICS INCgthp_10k.htm
 
Exhibit 32
 
SECTION 1350 CERTIFICATION
 
In connection with the Annual Report of Guided Therapeutics, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Gene Cartwright, President, Chief Executive Officer and Acting Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
 
(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
Date: April 5, 2021
 
/s/ Gene Cartwright 
Name: Gene Cartwright
Title: President, Chief Executive Officer and
          Acting Chief Financial Officer